• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Ascenta Therapeutics

edit

Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta’s current focus is a portfolio of novel, orally-active, small molecule drugs that restore the natural potential for cancer cells to undergo cell death (apoptosis).

Recent Milestones

edit

• 
  Ascenta Therapeutics added Louis Bock as Director.
  Posted 12/15/09 at 1:40pm

Videos

Screenshots

edit

Sources